COMMERCE BANK

Bank

Position in NBIX — Neurocrine Biosciences Inc

CIK 1009076 KANSAS CITY, MO

Position in NBIX

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$1,751,087

+$1,522,458 QoQ

Shares Held

13,292

+724.6% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 94.99699067108035.ToString("F0")% Shared 5.003009328919651.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

COMMERCE BANK holds $13,769,238 across 9 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (12.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	54,660	$6,461,357
2	VTRS	Viatris Inc	153,946	$2,079,809
3	NBIX	Neurocrine Biosciences Inc This page	13,292	$1,751,087
4	ELAN	Elanco Animal Health Inc	37,273	$891,942
5	UTHR	UNITED THERAPEUTICS Corp	1,274	$755,456
6	SUPN	Supernus Pharmaceuticals, Inc.	12,639	$653,309
7	HROW	Harrow, Inc.	17,430	$614,581
8	BCRX	Biocryst Pharmaceuticals Inc	38,310	$364,711

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,751,087	13,292	+724.6%	Shares	Sole	2026-05-11
2025-12-31	$228,629	1,612	+2.0%	Shares	Defined	2026-02-13
2025-09-30	$221,799	1,580	-62.4%	Shares	Defined	2025-11-12
2024-09-30	$483,808	4,199	+2.6%	Shares	Sole	2024-11-08
2024-06-30	$563,207	4,091	+88.9%	Shares	Sole	2024-08-12
2022-03-31	$203,062	2,166	-64.9%	Shares	Sole	2022-05-09
2021-06-30	$601,047	6,176	-0.2%	Shares	Sole	2021-08-09
2021-03-31	$601,782	6,188	+4.7%	Shares	Sole	2021-05-05
2020-12-31	$566,281	5,908	+53.7%	Shares	Sole	2021-02-09
2020-09-30	$369,542	3,843	+1.7%	Shares	Sole	2020-11-06
2020-06-30	$461,160	3,780	-0.3%	Shares	Sole	2020-08-07
2020-03-31	$328,196	3,792	—	Shares	Sole	2020-05-08
No filing history on record for this holder in this stock.